Skip to main content

Table 2 The EORTC QLQ-C30 and the QOL-H&N43 scores for the patients (n = 96)

From: Psychometric evaluation of Azeri version of the head and neck cancer specific quality of life questionnaire (EORTC QLQ-H&N43)

 

Mean

Standard deviation

Floor/ceiling effects (%)

QLQ-C30

Functioninga

  Physical functioning

90.5

13.7

0.0/12.7

  Role functioning

83.8

16.8

0.0/15.4

  Emotional functioning

72.1

17.0

0.0/5.4

  Cognitive functioning

86.5

20.2

0.0/9.7

  Social functioning

80.7

20.5

0.0/12.8

  Global quality of life

61.7

14.4

1.1/12.0

Symptomsb

  Fatigue

27.1

22.6

11.0/2.2

  Nausea and vomiting

8.51

17.2

3.3/13.0

  Pain

33.3

19.2

7.6//9.8

  Dyspnoea

16.6

22.3

14.4/10.8

  Insomnia

12.3

23.5

8.6/1.1

  Appetite loss

18.1

24.9

8.0/15.2

  Constipation

34.0

30.4

3.7/6.5

  Diarrhoea

23.9

28.0

8.9/4.3

  Financial difficulties

37.6

26.7

1.1/25.0

QLQ-H&N43b

 HN Pain

29.5

22.4

9.9/1.1

 HN Swallowing

29.6

16.4

4.3/5.4

 HN Senses problems

15.0

18.3

6.5/2.2

 HN Speech problems

26.3

16.7

5.4/1.1

 HN Trouble with social eating

28.0

18.2

10.9/0.0

 HN Less sexuality

21.4

27.3

4.9/2.2

 HN Problems with teeth

44.5

25.1

13.0/5.4

 HN Dry mouth/Sticky saliva

11.0

19.8

8.5/1.1

 HN Body image

24.8

21.1

13.9/0.0

 HN Shoulder pain

5.49

15.5

7.3/0.0

 HN Skin problems

7.65

17.0

12.0/1.1

 HN Anxiety

48.3

30.1

17.8/5.7

 HN Trouble with social contact

12.4

24.6

6.6/2.2

 HN Opening mouth

31.5

32.1

13.4/6.5

 HN Coughing

11.2

23.3

14.1/2.8

 HN Lymphedema

9.52

18.7

15.8/0.0

 HN Weight loss

27.0

31.5

14.4/1.1

 HN Problems wounds healing

12.9

21.6

12.1/4.4

 HN Neurological problems

11.1

21.1

13.8/2.2

  1. aHigher scores indicate better conditions
  2. bHigher scores indicate greater symptoms